Multi-Stage BioVentures, LP III
Multi-Stage BioVentures, LP III is a venture capital fund based in Bronxville, New York. According to its most recent Form D, filed Oct 12, 2021, it has sold $5,024,250 of interests to 15 investors since its first sale in Oct 2021. The minimum investment it accepts from an outside investor is $75,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Cognoscenti Capital, LLC; Jonathan Lawrence.
- Total raised
- $5,024,250Cumulative sales reported on Form D
- Investors
- 15
- First sale
- Oct 4, 2021
- Minimum investment
- $75,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Cognoscenti Capital, LLC; Jonathan Lawrence
- Latest Form D
- Oct 12, 2021
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Multi-Stage BioVentures, LP III
What is the minimum investment for Multi-Stage BioVentures, LP III?
According to its latest Form D, filed Oct 12, 2021, the minimum investment Multi-Stage BioVentures, LP III accepts from an outside investor is $75,000.
Who can invest in Multi-Stage BioVentures, LP III?
Multi-Stage BioVentures, LP III is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Multi-Stage BioVentures, LP III raised?
Multi-Stage BioVentures, LP III reports $5,024,250 sold from 15 investors on its Form D filed Oct 12, 2021. This is cumulative sales since the offering began, not current assets or performance.
Where is Multi-Stage BioVentures, LP III based?
Multi-Stage BioVentures, LP III is based in Bronxville, New York.
When did Multi-Stage BioVentures, LP III launch?
Multi-Stage BioVentures, LP III reports its first sale in Oct 2021.
Size compared with every venture capital fund
Raised more than 68% of the 1,239 venture capital funds based in New York, and more than 82% of all 14,865 that report sales.